Zivo Bioscience, Inc. Warrants
ZIVOW
ZIVOW was delisted on the 24th of November, 2023.
5 hedge funds and large institutions have $113K invested in Zivo Bioscience, Inc. Warrants in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
3% more capital invested
Capital invested by funds: $109K → $113K (+$3.74K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$2.89K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $64.5K | -$2.89K | -4,700 | -4% |
|
|
AC
2
Ayrton Capital
Westport,
Connecticut
| $29.3K | – | – | – |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| $8.05K | – | – | – |
|
|
VCA
4
Verdence Capital Advisors
Hunt Valley,
Maryland
| $6K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $5.05K | +$6.22K | +10,101 | New |
|
ZIVOW Hedge Fund Activity: Q2 2023 in Review
5 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q2 2023, worth a combined $113K — up 3.4% from $109K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ZIVOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.22K. The largest seller was Warberg Asset Management, cutting an estimated $2.89K.
- 5 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q2 2023, up from 4 in Q1 2023.
- Funds reported $113K of Zivo Bioscience, Inc. Warrants stock for Q2 2023, up 3.4% quarter-over-quarter.
- 1 fund opened new Zivo Bioscience, Inc. Warrants positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Zivo Bioscience, Inc. Warrants buyer in Q2 2023 was Citadel Advisors, an estimated $6.22K added.
- The largest Zivo Bioscience, Inc. Warrants seller in Q2 2023 was Warberg Asset Management, an estimated $2.89K sold.
Based on aggregated 13F filings for Q2 2023.